注册一亩三分地论坛,查看更多干货!
您需要 登录 才可以下载或查看附件。没有帐号?注册账号 
x
辉瑞公司周三表示,对其与BioNTech公司合作的疫苗进行的最终数据分析发现,该疫苗在预防Covid-19方面的有效性为95%,此外,似乎还能抵御严重的疾病。两天前,Moderna宣布,初步的三期试验数据显示其疫苗的有效性为94.5%。在疫情肆虐全球几乎所有国家后,制药商的数据让人们对全球经济很快恢复 "正常 "充满希望。这两种高效疫苗预计将在年底前获得美国食品和药物管理局的授权。
卫生和人类服务部部长 Alex Azar周一对表示:到2020年底,两家公司之间将有大约4000万剂疫苗可供使用,足以为大约2000万人接种。美国还与强生公司、赛诺菲和葛兰素史克公司、诺华公司和阿斯利康公司有Covid-19疫苗供应协议。
美国著名的传染病专家福奇博士预计,可能在明年的7月或在4月之前每个美国人都可以获得疫苗。
Pfizer said Wednesday that a final data analysis of its vaccine with BioNTech found it was 95% effective in preventing Covid-19 and, in addition, appeared to fend off severe disease. Two days earlier, Moderna announced that preliminary phase three trial data showed its vaccine was 94.5% effective. The data from the drugmakers raised hopes that the global economy could soon get back to “normal” after the pandemic wreaked havoc on nearly every country across the globe. The two highly effective vaccines are expected to be authorized by the U.S. Food and Drug Administration before the end of the year.
Health and Human Services Secretary Alex Azar told CNBC on Monday that there will be roughly 40 million doses of vaccine available by the end of this year between the two companies, enough to inoculate about 20 million people. The U.S. also has supply agreements for Covid-19 vaccines from Johnson & Johnson; Sanofi and GlaxoSmithKline; Novavax; and AstraZeneca.
Dr. Anthony Fauci, the nation’s leading infectious disease expert, expects that every American could get a vaccine by July or possibly by April. source
指尖新闻:高信噪比,一目了然
新冠疫情追踪 |